← AstraZeneca
Episodes featuring AstraZeneca
27 episodes, newest first.
- Sep 29, 2026
AI doubts hit Taiwan chips as Asian markets divergeStock MoversSep 29, 2026 - Sep 29, 2026
AI safety delays test labs’ revenue ambitionsWSJ What’s NewsSep 29, 2026 - Sep 29, 2026Chip contract and AI deal lift stocks as FICO faces disruptionStock MoversSep 29, 2026
- Sep 29, 2026Policy shift puts FICO’s credit-score dominance at riskStock MoversSep 29, 2026
- Sep 29, 2026
Three stock moves expose shifting deal and credit-score risksStock MoversSep 29, 2026 - Sep 29, 2026AI bets and credit-score rules reshape stock moversStock MoversSep 29, 2026
- Sep 29, 2026Asian stocks wobble as AI doubts meet drugmaking dealsStock MoversSep 29, 2026
- Sep 14, 2026Drug trial surprises move GSK and AstraZeneca sharesStock MoversSep 14, 2026
- Sep 13, 2026
Biotech’s rally tests the promise of cancer breakthroughsWSJ's Take On the WeekSep 13, 2026 - Sep 8, 2026
China turns biotech strength into strategic leverageOffice Hours with Prop GSep 8, 2026 - Aug 18, 2026
Why strong projects still fail without human judgmentTomorrow, TodayAug 18, 2026 - Aug 17, 2026Drug setbacks and copper demand reshape European stock movesStock MoversAug 17, 2026
- Aug 17, 2026Mining gains meet drug-trial surprises across European marketsStock MoversAug 17, 2026
- Aug 17, 2026European miners rise as drug trials reshape pharma stocksStock MoversAug 17, 2026
- Aug 17, 2026European shares split across drugs, copper and biotechStock MoversAug 17, 2026
- Aug 3, 2026Tyson Foods lowers outlook while AstraZeneca eyes Bristol Myers Squibb mergerStock MoversAug 3, 2026
- Aug 3, 2026AstraZeneca weighs historic merger while chip stocks stage a recoveryStock MoversAug 3, 2026
- Aug 3, 2026AstraZeneca plunges and BP divests as European markets undergo major shakeupsStock MoversAug 3, 2026
- Aug 3, 2026AstraZeneca drops on merger talks while airlines and shipping surgeStock MoversAug 3, 2026
- Aug 2, 2026
Mining deals and biotech catalysts shape a midsummer market reviewThe Sunday RoastAug 2, 2026 - Jul 27, 2026Argenx buys Forte Biosciences for billions as media merger talks stallStock MoversJul 27, 2026
- Jul 27, 2026Takeover bids and strong earnings push European stocks higherStock MoversJul 27, 2026
- Jul 10, 2026
Paul Scott makes the case for direct premium subscriptionsUK Small/Mid Caps with Paul ScottJul 10, 2026 - Jul 9, 2026Micron bets big on US chipmaking as drug trial rattles AstraZenecaStock MoversJul 9, 2026